Activation of host antitumoral responses by cationic lipid/DNA complexes

Cancer Gene Therapy

Volumn 7, Issue 3, 2000, Pages 353-359

  Bramson, Jonathan L ^a,b   Bodner, Carolyn A ^a   Graham, Roger W ^a  

^a Inex Pharmaceuticals Corporation   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cationic liposome; Gene therapy; Inflammation

Indexed keywords

AMMONIUM CHLORIDE; CATION; CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 12; LIPID; LIPOSOME; PLASMID DNA; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONITIS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0034127664     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700143     Document Type: Article

References (28)

1. Egilmez NK, Cuenca R, Yokota S, Sorgi F, Bankert RB. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. Gene Ther. 1996;3:607-614.
2. Hall SJ, Sanford MA, Atkinson G, Chen SH. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Cancer Res. 1998;58:3221-3225.
3. Shiratori Y, Kanai F, Hikiba Y, et al. Gene therapy for hepatic micrometastasis of murine colon carcinoma. J Hepatol. 1998;28:886-895.
4. Tahara H, Zitvogel L, Storkus WJ, et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol. 1995;154:6466-6474.
5. Karp SE, Farber A, Salo JC, et al. Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma: tumor inhibition by IL-2 but not TNF. J Immunol. 1993;150:896-908.
6. Parker SE, Khatibi S, Margalith M, et al. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. Cancer Gene Ther. 1996;3:175-185.
7. Blezinger P, Freimark BD, Matar M, et al. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases. Hum Gene Ther. 1999;10:723-731.
8. Scheule RK, St George JA, Bagley RG, et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther. 1997;8:689-707.
9. Freimark BD, Blezinger HP, Florack VJ, et al. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid:cationic lipid complexes. J Immunol. 1998;160:4580-4586.
10. Filion MC, Phillips NC. Anti-inflammatory activity of cationic lipids. Br J Pharmacol. 1997;122:551-557.
11. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979;7:1513-1523.
12. Mortimer I, Tam P, MacLachlan I, Graham RW, Saravolac EG, Joshi PB. Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther. 1999;6:403-411.
13. Bramson J, Hitt M, Gallichan WS, Rosenthal KL, Gauldie J, Graham FL. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin 12. Hum Gene Ther. 1996;7:333-342.
14. Khabar KSA, Siddiqui S, Armstrong JA. WEHI-13VAR: a stable and sensitive variant of WEHI 164 clone 13 fibrosarcoma for tumor necrosis factor bioassay. Immunol Lett. 1995;46:107-110.
15. Yang J-P, Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 1997;4:950-960.
16. Colombo MP, Forni G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today. 1994;15:48-51.
17. Xing Z, Gauldie J, Cox G, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101:311-320.
18. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol. 1998;10:259-264.
19. + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med. 1993;178:567-577.
20. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;329:245-252.
21. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol. 1997;15: 749-795.
22. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer. 1996;77:1226-1243.
23. + T-cell immunity. Cancer Gene Ther. 1998;5:321-330.
24. Xing X, Matin A, Yu D, et al. Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer. Cancer Gene Ther. 1996;3:168-174.
25. Yang J-P, Huang L. Direct gene transfer to mouse melanoma by intratumor injection of free DNA. Gene Ther. 1996;3:542-548.
26. Schwartz B, Benoist C, Abdallah B, et al. Gene transfer by naked DNA into adult mouse brain. Gene Ther. 1999;3: 405-411.
27. Nomura T, Yasuda K, Yamada T, et al. Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther. 1999;6:121-129.
28. 2-microglobulin gene in patients with cancer. Hum Gene Ther. 1998;9:2031-2038.